Beckley Psytech has announced that the first healthy volunteers have been dosed in a Phase I clinical trial exploring the safety and pharmacokinetics of BPL-003, Beckley Psytech’s second innovative formulation of 5-MeO-DMT.
Category Press Release
Published in Businewsswire
Companies Featured
Beckley PsytechBeckley Psytech is working on getting 5-MeO-DMT to market as the first of a variety of psychedelic medicines.